MULTI BAGGER ALERTS

[3DYOGI]

GOVX 50 Million shares outstanding 3 Million market cap.

Furthest along HIV vaccine in the world.

#2 Vaccine Scientist.

#22 Vaccine scientist.

Global Vaccine Market Surging to More Than $70 Billion by 2024 thats 25x the size of medical marijuana industry of 3 Billion by 2020.

Deep Pipeline Zika, HIV, Multiple cancer vaccines, Malaria, Hep B, Ebola,

Sabby Management increase its ownership from 3 million shares in 2016 to well over 5 Million in 2017 shares and 10% ownership of the company

Emory University 10% owner of GOVX

http://www.insidercow.com/institution/subject.jsp;jsessionid=AF97F8D3C0B13A22DC772DA7B9259D08?subject=0000832489&company=null

https://www.geovax.com/clinical-pipeline.html

http://scr.zacks.com/News/Press-Releases/Press-Release-Details/2016/GOVX-GeoVax-to-Develop-Vaccine-against-Zika-Virus/default.aspx

https://www.geovax.com/investors.html


http://scr.zacks.com/News/Press-Releases/Press-Release-Details/2017/GOVX-Multiple-Progress-Made-in-the-Last-Two-Months/default.aspx

http://paxvax.com/sites/default/files/pdf/vaccinenation-2014-most-influential-people-in-vaccines.pdf

https://www.geovax.com/images/GeoVax_-_GOVX-B11_White_Paper_Feb_2017.pdf

Compared to its peers its extremely undervalued:

NVAX 375 Million Market cap VLP Platform
GOVX 3 Million Market Cap

This is the most under valued stock on the OTCQB has billion dollar market value potential with the HIV Vaccine alone. Plus Zika, Ebola, Malaria, Hep b, Fever Vaccines, multiple immunotherapy-cancer vaccines. Over 50 Million in grants from NIH CDC and working with some of the top Universities in the world to move there pipeline to market with world renown scientist. #2 & #22 recently taking lead positions at the companies two of the top two vaccine scientist only take a lead job at a biotech if they think there is something to the Vaccine Technology!

25K Investment could reap millions at these price levels
.
Bottomed last week with a volume increase last few days of the week with healthy price movement to the upside.